Fate Therapeutics Inc
NASDAQ:FATE
Income Statement
Earnings Waterfall
Fate Therapeutics Inc
Revenue
|
63.5m
USD
|
Operating Expenses
|
-254m
USD
|
Operating Income
|
-190.5m
USD
|
Other Expenses
|
29.6m
USD
|
Net Income
|
-160.9m
USD
|
Income Statement
Fate Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1
N/A
|
1
-48%
|
0
-58%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+312%
|
2
+79%
|
4
+55%
|
4
+19%
|
4
N/A
|
4
-1%
|
4
-6%
|
4
N/A
|
4
N/A
|
4
0%
|
4
+0%
|
4
N/A
|
4
N/A
|
5
+15%
|
6
+34%
|
8
+28%
|
10
+17%
|
11
+12%
|
11
-1%
|
13
+25%
|
18
+39%
|
31
+71%
|
40
+27%
|
48
+20%
|
55
+14%
|
56
+2%
|
63
+13%
|
68
+8%
|
69
+1%
|
96
+40%
|
137
+42%
|
119
-13%
|
106
-11%
|
64
-40%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(19)
|
(22)
|
(23)
|
(24)
|
(25)
|
(26)
|
(27)
|
(28)
|
(30)
|
(32)
|
(34)
|
(36)
|
(36)
|
(38)
|
(40)
|
(42)
|
(46)
|
(50)
|
(60)
|
(67)
|
(72)
|
(80)
|
(86)
|
(98)
|
(111)
|
(125)
|
(133)
|
(142)
|
(160)
|
(180)
|
(206)
|
(236)
|
(273)
|
(308)
|
(350)
|
(382)
|
(405)
|
(399)
|
(361)
|
(313)
|
(254)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(12)
|
(12)
|
(14)
|
(15)
|
(16)
|
(18)
|
(19)
|
(21)
|
(24)
|
(26)
|
(28)
|
(30)
|
(34)
|
(39)
|
(43)
|
(51)
|
(57)
|
(66)
|
(74)
|
(80)
|
(84)
|
(85)
|
(88)
|
(85)
|
(81)
|
|
Research & Development |
(12)
|
(14)
|
(15)
|
(16)
|
(16)
|
(16)
|
(17)
|
(18)
|
(20)
|
(22)
|
(24)
|
(26)
|
(26)
|
(28)
|
(29)
|
(31)
|
(34)
|
(38)
|
(47)
|
(52)
|
(56)
|
(62)
|
(67)
|
(77)
|
(88)
|
(99)
|
(104)
|
(112)
|
(126)
|
(141)
|
(163)
|
(185)
|
(216)
|
(243)
|
(276)
|
(303)
|
(320)
|
(314)
|
(274)
|
(228)
|
(173)
|
|
Operating Income |
(18)
N/A
|
(21)
-20%
|
(23)
-8%
|
(24)
-4%
|
(25)
-4%
|
(26)
-3%
|
(27)
-5%
|
(27)
+0%
|
(28)
-4%
|
(28)
-2%
|
(29)
-3%
|
(31)
-7%
|
(32)
-2%
|
(34)
-6%
|
(36)
-5%
|
(38)
-5%
|
(42)
-12%
|
(46)
-10%
|
(56)
-22%
|
(63)
-11%
|
(67)
-7%
|
(73)
-10%
|
(78)
-6%
|
(88)
-13%
|
(101)
-14%
|
(115)
-14%
|
(119)
-4%
|
(124)
-4%
|
(128)
-3%
|
(140)
-9%
|
(158)
-13%
|
(181)
-15%
|
(217)
-20%
|
(245)
-13%
|
(282)
-15%
|
(313)
-11%
|
(308)
+2%
|
(263)
+15%
|
(242)
+8%
|
(207)
+15%
|
(191)
+8%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
2
|
3
|
3
|
3
|
3
|
(25)
|
(45)
|
(45)
|
(54)
|
(16)
|
5
|
13
|
28
|
19
|
26
|
23
|
21
|
24
|
20
|
|
Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
5
|
9
|
10
|
10
|
|
Pre-Tax Income |
(21)
N/A
|
(24)
-16%
|
(25)
-2%
|
(25)
-2%
|
(26)
-2%
|
(27)
-3%
|
(28)
-6%
|
(29)
-1%
|
(30)
-4%
|
(31)
-2%
|
(31)
-2%
|
(33)
-6%
|
(33)
-1%
|
(35)
-5%
|
(36)
-4%
|
(38)
-5%
|
(43)
-12%
|
(47)
-9%
|
(57)
-21%
|
(63)
-11%
|
(67)
-6%
|
(72)
-8%
|
(76)
-5%
|
(86)
-13%
|
(98)
-14%
|
(112)
-14%
|
(117)
-4%
|
(149)
-28%
|
(173)
-17%
|
(185)
-7%
|
(212)
-15%
|
(197)
+7%
|
(212)
-8%
|
(233)
-10%
|
(254)
-9%
|
(294)
-16%
|
(282)
+4%
|
(235)
+17%
|
(212)
+10%
|
(173)
+18%
|
(161)
+7%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(21)
|
(24)
|
(25)
|
(25)
|
(26)
|
(27)
|
(28)
|
(29)
|
(30)
|
(31)
|
(31)
|
(33)
|
(33)
|
(35)
|
(36)
|
(38)
|
(43)
|
(47)
|
(57)
|
(63)
|
(67)
|
(72)
|
(76)
|
(86)
|
(98)
|
(112)
|
(117)
|
(149)
|
(173)
|
(185)
|
(212)
|
(197)
|
(212)
|
(233)
|
(254)
|
(294)
|
(282)
|
(235)
|
(212)
|
(173)
|
(161)
|
|
Net Income (Common) |
(21)
N/A
|
(24)
-16%
|
(25)
-2%
|
(25)
-2%
|
(26)
-2%
|
(27)
-3%
|
(28)
-6%
|
(29)
-1%
|
(30)
-4%
|
(31)
-2%
|
(31)
-2%
|
(33)
-6%
|
(33)
-1%
|
(35)
-5%
|
(36)
-4%
|
(38)
-5%
|
(43)
-12%
|
(47)
-9%
|
(57)
-21%
|
(63)
-11%
|
(67)
-6%
|
(72)
-8%
|
(76)
-5%
|
(86)
-13%
|
(98)
-14%
|
(112)
-14%
|
(117)
-4%
|
(149)
-28%
|
(173)
-17%
|
(185)
-7%
|
(212)
-15%
|
(197)
+7%
|
(212)
-8%
|
(233)
-10%
|
(254)
-9%
|
(294)
-16%
|
(282)
+4%
|
(235)
+17%
|
(212)
+10%
|
(173)
+18%
|
(161)
+7%
|
|
EPS (Diluted) |
-1.1
N/A
|
-1.19
-8%
|
-1.21
-2%
|
-1.23
-2%
|
-1.27
-3%
|
-1.3
-2%
|
-1.19
+8%
|
-1
+16%
|
-1.18
-18%
|
-1.05
+11%
|
-1.08
-3%
|
-1.02
+6%
|
-1.05
-3%
|
-0.85
+19%
|
-0.88
-4%
|
-0.94
-7%
|
-1.02
-9%
|
-0.89
+13%
|
-1.07
-20%
|
-1.16
-8%
|
-1.19
-3%
|
-1.11
+7%
|
-1.16
-5%
|
-1.28
-10%
|
-1.44
-13%
|
-1.47
-2%
|
-1.46
+1%
|
-1.7
-16%
|
-2.1
-24%
|
-1.97
+6%
|
-2.24
-14%
|
-2.06
+8%
|
-2.24
-9%
|
-2.43
-8%
|
-2.64
-9%
|
-3.05
-16%
|
-2.91
+5%
|
-2.39
+18%
|
-2.15
+10%
|
-1.77
+18%
|
-1.64
+7%
|